02 May 2013, BioSpectrum Bureau , BioSpectrum
Singapore: Bausch + Lomb, the global eye health company has been appointed as distributor of several lines of intraocular lense manufacturer, PhysIOL's hydrophilic acrylic intraocular lenses (IOLs) in select markets across Asia, Europe and the Middle East.
As per the terms of the agreement, Bausch + Lomb will begin to distribute PhysIOL's FineVision trifocal and FineVision trifocal toric hydrophilic, UV and blue-blocking, aspheric intraocular lenses, and, when available, the Ankoris toric lenses on an exclusive or co-exclusive basis depending on the market.
Additionally, Bausch + Lomb will distribute PhysIOL's Micro line of hydrophilic preloaded, UV and blue-blocking, aspheric monofocal intraocular lenses in limited markets. The companies have the option to expand the distribution relationship over time. PhysIOL's portfolio complements Bausch + Lomb's extensive line of hydrophobic and hydrophilic acrylic IOLs, including the enVista, Crystalens, and Akreos brands of IOLs for implantation after cataract removal.
Mr Marc Nolet, chief executive officer, PhysIOL, said that, "This partnership with Bausch + Lomb gives PhysIOL a perfect opportunity to leverage its R&D through a worldwide distribution network and in combination with a comprehensive line of equipment, instruments and other surgical products."
"The PhysIOL team has developed an impressive assortment of hydrophilic acrylic intraocular lenses - that complements Bausch + Lomb's existing portfolio of lenses," said Mr John Barr, executive vice president and president, Bausch + Lomb Global Surgical. "We are excited to provide ophthalmic surgeons with a greater choice when selecting an intraocular lens best suited for their patient's needs, and look forward to broadening the reach of PhysIOL's products through our established global commercial infrastructure."